Compare Rajnish Wellness with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -2.26
- The company has been able to generate a Return on Equity (avg) of 0.41% signifying low profitability per unit of shareholders funds
Flat results in Mar 26
Risky - Negative EBITDA
Stock DNA
Pharmaceuticals & Biotechnology
INR 46 Cr (Micro Cap)
NA (Loss Making)
45
0.00%
-0.09
-5.20%
0.44
Total Returns (Price + Dividend) 
Rajnish Wellness for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Rajnish Wellness Ltd is Rated Strong Sell
Rajnish Wellness Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news articleAre Rajnish Wellness Ltd latest results good or bad?
The latest financial results for Rajnish Wellness Ltd reveal a complex picture characterized by significant revenue growth alongside severe operational challenges. In the quarter ending March 2026, the company reported net sales of ₹101.95 crores, reflecting a remarkable 338.68% increase compared to the previous quarter. This growth is notable year-on-year as well, with a staggering 1,666.90% rise. However, this topline expansion appears to be overshadowed by a substantial net loss of ₹4.70 crores, which widened from a loss of ₹0.91 crores in the previous quarter, indicating deteriorating profitability. The operating margin for the same quarter stood at -6.70%, marking the worst performance in seven quarters and a decline from -5.90% in the prior quarter. This suggests that the company is facing significant cost control issues, as the increase in revenue has not translated into operational efficiency. The ...
Read full news article
Rajnish Wellness Q4 FY26: Heavy Losses Overshadow Revenue Surge
Rajnish Wellness Ltd., a micro-cap pharmaceutical company engaged in selling consumer durables and ayurvedic personal care products, reported deeply troubling results for Q4 FY26 (January-March 2026), with net losses ballooning to ₹4.70 crores despite a dramatic 338.68% quarter-on-quarter revenue surge. The loss marks a stark reversal from the previous quarter's loss of ₹0.91 crores and represents a staggering 1,624.8% deterioration compared to the average of the preceding four quarters.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
01-Jun-2026 | Source : BSEAnnouncement under Regulation 30 (LODR)- Newspaper Publication.
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday 30Th May 2026
30-May-2026 | Source : BSEOutcome of Board Meeting held today i.e Saturday 30th May 2026
Declaration Of Results For The Quarter And Year Ended 31St March 2026.
30-May-2026 | Source : BSEDeclaration of Results for the Quarter and Year ended 31st March 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Rajnish Wellness Ltd has announced 1:2 stock split, ex-date: 10 Jan 23
Rajnish Wellness Ltd has announced 2:1 bonus issue, ex-date: 21 Jul 22
Rajnish Wellness Ltd has announced 19:30 rights issue, ex-date: 03 Jun 25
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 0 Schemes
Held by 1 FIIs (0.43%)
Rajnish Kumar Singh (9.16%)
Jasmit Singh Chandhok (1.92%)
86.0%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 338.68% vs 93.67% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -416.48% vs -1,616.67% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -50.89% vs 24.80% in Sep 2024
Growth in half year ended Sep 2025 is -36.36% vs -32.31% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -6.97% vs -12.05% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -223.53% vs -32.00% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 191.91% vs -36.67% in Mar 2025
YoY Growth in year ended Mar 2026 is -3,800.00% vs -83.50% in Mar 2025






